Thank you, Farooq, and thank you all for taking the time to join us this morning. This result reflects the considerable effort we have put into successfully mechanizing Xavantina to make it safe and ...
NVTS heads into Q1 earnings with a steep revenue decline expected, as AI-driven GaN and SiC demand competes with pressure ...
KIOXIA America, Inc. today announced the KIOXIA BG8 Series solid state drives (SSDs), the next evolution of its client SSD lineup designed for PC OEM customers. Delivering PCIe ® 5.0 speed to the ...
SCOTUSblog on MSN
Court decides major Voting Rights Act case
Plus, the justices heard argument on Wednesday on the Trump administration’s effort to revoke temporary protected status from ...
Researchers from Zhejiang University and their collaborators have developed Qjump, a hybrid quantum-classical algorithm for tackling combinatorial optimization problems. By combining shallow-circuit ...
Western Digital Corporation ( WDC) Q3 2026 Earnings Call April 30, 2026 4:30 PM EDT Good afternoon, and thank you for standing by. Welcome to Western Digital's Third Quarter Fiscal 2026 Conference ...
KIOXIA is looking to ease the burden on consumers and PC OEMs with new affordable and mainstream SSD options, including the ...
Kioxia has announced its new KIOXIA EG7 Series SSDs, marking the company’s first client drives built on its BiCS FLASH generation 8 QLC (4-bit-per-cell) technology. The new lineup is aimed squarely at ...
Kioxia is continuing its effort to bring more affordable storage options to the mainstream market, this time with the introduction of its BG8 series that aims to deliver PCI Express 5.0 speeds to a ...
Q1 2026 earnings call recap: record $804M revenue, comms surge, Enterprise Data growth floor to 85%, margin risks—read now.
KIOXIA America, Inc. today announced KIOXIA EG7 Series solid state drives (SSDs), the company’s first client solution to adopt KIOXIA’s BiCS FLASH™ generation 8 4-bit-per-cell, quadruple-level cell ...
Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results